Future care preferences in Auckland District Health Board,Dr Dr Alex 13/NTA/38 Approve patients with advanced liver Samantha Everitt,Waitemata Observational Smith cirrhosis District Health Board Auckland District Health Dr Douglas Iupati,Dr Board,CDHB Research Office,Dr 13/NTA/39 Approve CHISEL Dr Christine Elder Nikolay Nedev,Doctor Scott Intervention Kenneth Clark,Helen White for Babington Marina Dzhelali PEME for the Treatment of 13/NTA/40 Approve Dr Tumilty Karen Keith Intervention Low Back Pain Dr David Milne,Dr Kenneth Correlation of functional and Whyte,Dr Kevin Ellyett,Dr 13/NTA/41 Approve morphological change in the Dr Clair King Observational Margaret Wilsher,Associate ageing lung. Professor Merryn Tawhai A trial assessing Sovaprevir Auckland Clinical Studies and ACH-0143102 in Professor 13/NTA/42 Approve Ltd,Chris Taylor, Christchurch Intervention treatment naive patients with Edward/EJG Gane Clinical Studies Trust Chronic HCV. Desvenlafaxine 1 x 100 mg bioequivalence study 13/NTA/43 Approve conducted under fasting Dr Noelyn Hung Intervention conditions and at steady state Desvenlafaxine 1 x 50 mg bioequivalence study 13/NTA/44 Approve Dr Noelyn Hung Intervention conducted under fasting conditions Desvenlafaxine 1 x 100 mg bioequivalence study 13/NTA/45 Approve Dr Noelyn Hung Intervention conducted under fed conditions Desvenlafaxine 1 x 100 mg bioequivalence 13/NTA/46 Approve Dr Noelyn Hung Intervention conducted under fasting conditions Violence, Substance Abuse, 13/NTA/51 Approve Reports of Concern and Dr Patrick Dr Santuri Rungan Auckland District Health Board Observational Non-Accidental Head Injury.
13/NTA/38 Approve Future care preferences in patients with advanced liver cirrhosis Dr Alex Auckland District Health Board,Dr Samantha Everitt,Waitemata District Health Board Observational 13/NTA/39 Approve CHISEL Dr Christine Elder Dr Douglas Iupati,Dr Nikolay Nedev,Doctor Scott Babington Auckland District Health Board,CDHB Research Office,Dr Kenneth Clark,Helen White for Marina Dzhelali Intervention 13/NTA/40 Approve PEME for the Treatment of Low Back Pain Dr Tumilty Karen Keith Intervention 13/NTA/41 Approve Correlation of functional and morphological change in the ageing lung. Dr Clair King Dr David Milne,Dr Kenneth Whyte,Dr Kevin Ellyett,Dr Margaret Wilsher,Associate Professor Merryn Tawhai Observational 13/NTA/42 Approve A trial assessing Sovaprevir and ACH-0143102 in treatment naive patients with Chronic HCV. Professor Edward/EJG Gane Auckland Clinical Studies Ltd,Chris Taylor, Christchurch Clinical Studies Trust Intervention 13/NTA/43 Approve Desvenlafaxine 1 x 100 mg bioequivalence study conducted under fasting conditions and at steady state Dr Noelyn Hung Intervention 13/NTA/44 Approve Desvenlafaxine 1 x 50 mg bioequivalence study conducted under fasting conditions Dr Noelyn Hung Intervention 13/NTA/45 Approve Desvenlafaxine 1 x 100 mg bioequivalence study conducted under fed conditions Dr Noelyn Hung Intervention 13/NTA/46 Approve Desvenlafaxine 1 x 100 mg bioequivalence conducted under fasting conditions Dr Noelyn Hung Intervention 13/NTA/51 Approve Violence, Substance Abuse, Reports of Concern and Non-Accidental Head Injury. Dr Patrick Dr Santuri Rungan Auckland District Health Board Observational Smith
northern-a-ethics-committee-annual-report-2013.docx